Molecular Quality Controls Market Overview and Forecast by 2031
分子质量控制市场规模预计将从 2023 年的 2.2 亿美元增至 2031 年的 5.2 亿美元。预计 2023-2031 年期间该市场的复合年增长率将达到 12.8%。个性化医疗需求的不断增长可能仍将是市场的主要趋势。
分子质量控制市场分析
基因组学资金不断增长以及遗传病患病率不断上升等因素推动了市场的增长。此外,对分子诊断的关注度不断提高,也成为分子质量控制市场参与者的关键机遇。
分子质量控制市场概况
几年前,基因组测序还仅限于研究机构。然而,它现在已成为临床实践中的标准技术之一。根据“将基因组学融入医疗保健”的研究,未来几年,医疗保健行业预计将生成超过 6000 万患者的基因组数据。医疗保健系统中基因组测序的不断实施得到了政府大量投资的支持,至少有 14 个国家的政府投资总额超过 40 亿美元。英国宣布了世界上最大的基因组项目,这是慈善组织和制药公司之间 2 亿美元公私合作的一部分。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
分子质量控制市场:
复合年增长率(2023 - 2031)12.8%- 2023 年市场规模
2.2 亿美元 - 2031年市场规模
5.2亿美元
市场动态
- 制造商和政府在基因组学领域的资金投入增加,支持了分子质量控制市场的增长
- 基于患者基因信息的个性化医疗的日益普及预计将成为分子质量控制市场的一个显著趋势
- 对分子诊断的日益关注正成为分子质量控制市场参与者的关键机遇
关键人物;主力;重要一员
- 赛默飞世尔科技股份有限公司
- 智诺斯
- BIO-RAD 实验室公司
- F.霍夫曼拉罗什有限公司
- 雅培、Quidel 公司
- 缅因分子控制有限公司
- Zeptometrix 公司
- 微生物制剂
- Seracare 生命科学
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 独立控制
- 仪器特定控制
- 单一分析物对照
- 多分析物控制
- 传染性疾病
- 肿瘤学
- 基因检测
- 其他应用
- 临床实验室
- 医院
- IVD 制造商和合同研究组织
- 学术及研究机构
- 其他最终用户
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
分子质量控制市场驱动因素和机遇
遗传病患病率不断上升
由于分子质量控制有助于解释结果,因此它们被用于检测遗传疾病。21 号染色体的额外完整或部分拷贝会导致异常细胞分裂,从而产生唐氏综合症这种遗传疾病。根据美国疾病控制和预防中心 (CDC) 的数据,美国每年约有 6,000 名婴儿患有唐氏综合症。因此,唐氏综合症的产前检测在全国范围内不断增加。
大多数遗传性乳腺癌病例中,BRCA1(乳腺癌基因一)和 BRCA2(乳腺癌基因二)这两个基因都会发生突变。根据美国癌症协会的数据,从父母遗传给后代的缺陷基因占遗传性乳腺癌病例的 5% 至 10%。随着人们对乳腺癌的认识不断提高,遗传性乳腺癌的基因检测变得越来越流行。
分子诊断应用率上升
分子诊断方法用于检测 DNA 或 RNA 中特定序列之间的异常。单核苷酸多态性 (SNP)、缺失、重排和插入等异常会导致各种疾病,例如传染病、癌症、病毒性疾病和性传播疾病 (STD)。
根据《流感事实和统计报告》,2017-2018年,因流感就诊的门诊量约为3140万人次。报告还提到,美国每年有5-20%的人口患流感。此外,根据美国国家癌症研究所的数据,2020年,美国将诊断出约1,806,590例新癌症病例,预计死亡人数为606,520人。预计到2024年,癌症患者人数将上升到1900万人。传染病的流行率如此之高,癌症发病率不断上升,导致分子诊断受到高度关注,因为它能够以高特异性诊断疾病,为精准医疗治疗患者铺平了道路。
分子质量控制市场报告细分分析
有助于得出分子质量控制市场分析的关键部分是产品、应用和最终用户。
- 根据产品,分子质量控制市场细分为独立控制和仪器特定控制);分析物类型(单分析物控制和多分析物控制)。独立控制部分在 2023 年占据了最大的市场份额。
- 根据应用,分子质量控制市场分为传染病、肿瘤学、基因检测和其他应用。传染病领域在 2023 年占据了最大的市场份额。
- 根据最终用户,分子质量控制市场分为临床实验室、医院、体外诊断制造商和合同研究组织、学术和研究机构、其他最终用户。临床实验室部分在 2023 年占据了最大的市场份额。
分子质量控制市场份额按地区分析
分子质量控制市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。
在北美,美国是最重要的分子质量控制市场。制造公司以及学术和研究机构在开发癌症药物、老年人口增长、传染病和其他治疗方面的投资和资金不断增加是主要驱动因素之一。
人们普遍认为,基于 NGS 的诊断将在未来指导治疗选择,以改善患者的治疗效果。根据美国国家癌症研究所的数据,2020 年美国预计将诊断出 1,806,590 例新癌症病例,其中 606,520 人死于癌症。同样,根据白血病和淋巴瘤协会 (LLS) 的数据,2020 年美国预计将有 178,520 人被诊断出患有白血病、淋巴瘤或骨髓瘤。因此,上述因素将在预测的时间范围内推动市场增长。
分子质量控制市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 2.2亿美元 |
2031 年市场规模 | 5.2亿美元 |
全球复合年增长率(2023 - 2031) | 12.8% |
历史数据 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
分子质量控制市场新闻和最新发展
分子质量控制市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。分子质量控制市场的一些发展如下所列:
- 雅培和 Personalis, Inc. 已达成合作协议,开发和分销用于下一代测序 (NGS) 研究的液体活检对照品。此次合作的目的是提高液体活检程序在检测和追踪癌症方面的精确度和可靠性。(来源:雅培,公司网站,2024 年 5 月)
- Qiagen 称,现已推出针对巨细胞病毒、乙肝病毒 (HBV) 和 SARS-CoV-2 的新型 QuantiTect 病毒载量控制。这些控制满足了临床环境中对准确病毒感染监测日益增长的需求。(来源:Qiagen,公司网站,2024 年 1 月)
分子质量控制市场报告覆盖范围和交付成果
“分子质量控制市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:
- 范围内涵盖的所有关键细分市场的全球、区域和国家层面的分子质量控制市场规模和预测
- 分子质量控制市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 分子质量控制市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及分子质量控制市场的最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the molecular quality controls market in 2023
Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.
The burgeoning demand for personalized Medicine will likely remain a key trend in the market.
THERMO FISHER SCIENTIFIC, INC., Qnostics, BIO-RAD LABORATORIES, INC., F. HOFFMANN LA-ROCHE LTD., Abbott, Quidel Corporation, Maine Molecular Controls, Inc., Zeptometrix Corporation, Microbiologics, and Seracare Life Sciences.
The market is expected to register a CAGR of 12.8% during 2023–2031.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.